Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa
一项针对日本中重度化脓性汗腺炎患者的阿达木单抗3期开放标签试验的24周中期分析
期刊:Journal of Dermatology
影响因子:2.7
doi:10.1111/1346-8138.14997
Morita, Akimichi; Takahashi, Hidetoshi; Ozawa, Kentaro; Imafuku, Shinichi; Nakama, Takekuni; Takahashi, Kenzo; Matsuyama, Takashi; Okubo, Yukari; Kitamura, Susumu; Matsuda, Naoto; Zhao, Yiwei; Yokoyama, Masayuki; Hayashi, Nobukazu; Terui, Tadashi